# HCA Healthcare, Inc.: Form 10-Q for the period ended Jun 30, 2021

- Company: [HCA Healthcare, Inc.](/companies/hca.md) (CIK 860730)
- Form: 10-Q
- Filed: 2021-08-02
- Accepted by EDGAR: Aug 2, 2021, 16:37 ET
- Period: 2021-06-30
- Accession: 0001193125-21-233345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/860730/000119312521233345/d153845d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/860730/000119312521233345/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Interest expense | 3 months, 2021-04-01 to 2021-06-30 | $386.0m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2021-01-01 to 2021-06-30 | $770.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-04-01 to 2021-06-30 | $453.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2021-01-01 to 2021-06-30 | $846.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-04-01 to 2021-06-30 | $1.45bn | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2021-01-01 to 2021-06-30 | $2.87bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-04-01 to 2021-06-30 | $4.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2021-01-01 to 2021-06-30 | $8.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-04-01 to 2021-06-30 | $4.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2021-01-01 to 2021-06-30 | $8.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-04-01 to 2021-06-30 | 332,613,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2021-01-01 to 2021-06-30 | 337,940,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2021-01-01 to 2021-06-30 | $4.24bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2021-01-01 to 2021-06-30 | $1.50bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2021-01-01 to 2021-06-30 | $325.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2021-01-01 to 2021-06-30 | $3.81bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-06-30 | $1.12bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-06-30 | $12.47bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-06-30 | $48.16bn | us-gaap:Assets |
| Current liabilities | at 2021-06-30 | $8.62bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2021-06-30 | $32.32bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-06-30 | $253.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-06-30 | −$593.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/860730/000119312521233345/d153845d10q.htm

Filed Aug 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-233345. Last ingested by Listed: Nov 11, 2026, 03:15 ET. No prices; not investment advice.
